Women's healthcare vendor Hologic of Bedford, MA, posted solid growth in revenues for its first quarter of fiscal 2011 (end-December 31), driven in part by rising service revenues from the company's installed base of mammography systems.
For the quarter, Hologic posted sales of $432.6 million, up 5% compared with sales of $412.4 million in the first quarter of 2010. The company said that it saw revenue growth of 9.1% in its Breast Health business, due to sales of its 2D/3D Dimensions mammography system, increased service revenues, sales from its acquisition of Sentinelle, and revenues from the company's Eviva breast biopsy unit. The growth was partially offset by a reduction in the number of Selenia mammography systems sold.
For the quarter, the company turned in net income of $10.9 million, compared with net income of $26.1 million in the same quarter a year ago. The current quarter's profit was affected by a one-time charge of $29.9 million related to a loss on extinguishment of debt that did not appear in last year's results. Operating income for the most recent quarter was $71.7 million, down slightly from $72 million in the corresponding quarter the year before.
Related Reading
Hologic taps GM for diagnostics group, January 31, 2011
Hologic acquires Interlace Medical, January 7, 2011
Hologic teams with SuperSonic Imagine, November 24, 2010
Hologic's Selenia nets FDA letter, November 23, 2010
Hologic posts mixed results for FY 2010, November 9, 2010
Copyright © 2011 AuntMinnie.com











![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&fit=crop&h=112&q=70&w=112)






